American Healthcare REIT, Inc. AHR
Set alert
53.90 USD +0.11 +0.20%
As of Nov 3, 9:38 AM ET
53.49 Day range 53.98
44.81 52-week range 58.70
- YTD
- +14.53%
- 1 year
- +17.81%
- Open
- 53.62
- Prev close
- 53.79
- Mkt cap
- 11.71B
- Vol
- 16.19K
- Avg vol
- 3.14M
- EPS
- 0.67
- P/E
- 80.19
- Div yield
- 1.89%
More statistics
- Low
- 53.49
- High
- 53.98
- Forward P/E
- 54.35
- Beta
- 0.79
- Short ratio
- 9.67
- Inst. own
- 102.74%
- Dividend
- 1.00
- Ex-div date
- Sep 29, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 53.17
- 200-d avg
- 51.47
- 1y target
- 63.69
MAX chart
Events in this range
- Mar 27, 2024Dividend: 0.25
- Jun 27, 2024Dividend: 0.25
- Sep 20, 2024Dividend: 0.25
- Dec 31, 2024Dividend: 0.25
- Mar 31, 2025Dividend: 0.25
- Jun 30, 2025Dividend: 0.25
- Aug 7, 2025Earnings: 0.06; estimate 0.4; surprise -85%
- Sep 30, 2025Dividend: 0.25
- Nov 6, 2025Earnings: 0.33; estimate 0.42; surprise -21.43%
- Dec 31, 2025Dividend: 0.25
- Feb 26, 2026Earnings: 0.06; estimate 0.1549; surprise -61.27%
- Mar 31, 2026Dividend: 0.25
- May 7, 2026Earnings: 0.13; estimate 0.1609; surprise -19.2%
- Jun 30, 2026Dividend: 0.25
- Aug 6, 2026Earnings: 0.16; estimate 0.1372; surprise 16.62%
- Aug 19, 2026Rating: Keybanc · Overweight → Overweight
- Aug 31, 2026Rating: Barclays · Overweight → Overweight
- Sep 2, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
- Sep 30, 2026Dividend: 0.25
- Oct 13, 2026Rating: Raymond James · — → Strong Buy
- Oct 13, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: UBS · Buy → Buy
Signals (41)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Overbought | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
Newest 20 of 41.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 63.69 +18.2% upside
Now 53.90
- Target (low)
- 55.00
- Target (mean)
- 63.69
- Target (high)
- 74.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy6
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.16 | 0.16 – 0.16 | 0.2681 | -40.3% | 724.84M | +26.5% | 1 |
| Next quarter | 0.20 | 0.20 – 0.20 | 0.1437 | +39.2% | 773.94M | +28.1% | 1 |
| Current year | 0.61869 | 0.56 – 0.68 | 0.42 | +47.3% | 2.81B | +24.2% | 5 |
| Next year | 0.99 | 0.99 – 0.99 | 0.00 | 0.0% | 3.29B | +17.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | UBS | Maintained | Buy | Buy |
| Oct 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 13, 2026 | Raymond James | Initiated | — | Strong Buy |
| Sep 2, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Aug 31, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 27, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 21, 2026 | Compass Point | Initiated | — | Buy |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| Jul 7, 2026 | Barclays | Initiated | Overweight | Overweight |
| Jun 23, 2026 | Citigroup | Upgrade | Neutral | Buy |
| Jun 18, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| May 28, 2026 | Keybanc | Maintained | Overweight | Overweight |
| May 26, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 11, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Mar 2, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 5, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Jan 29, 2026 | BMO Capital | Initiated | — | Outperform |
| Jan 20, 2026 | Truist Securities | Maintained | Buy | Buy |
| Nov 26, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 21, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Nov 20, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 17, 2025 | UBS | Maintained | Buy | Buy |
| Nov 13, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Nov 13, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Nov 12, 2025 | RBC Capital | Maintained | Outperform | Outperform |